Nomos Goes Public Via North American Scientific Merger Valued At $56 Mil.
This article was originally published in The Gray Sheet
Executive Summary
Radiation oncology firm North American Scientific, Inc. (NASI) will more than triple its revenue to $55-$60 mil. with the purchase of intensity modulated radiation therapy (IMRT) developer Nomos under an Oct. 27 agreement
You may also be interested in...
NASI to divest imaging agent R&D
North American Scientific, Inc. will prioritize intensity modulated radiation therapy (IMRT) and image guided radiation therapy (IGRT) oncology therapeutics by redirecting a portion of the $10 mil. annual savings that will result from a planned divestiture of its Theseus radiopharmaceutical R&D operation, the firm says. NASI bought Theseus for about $18.5 mil. in 2000; its primary product candidate is the Hynic-Annexin V nuclear imaging agent for determining early response to chemotherapy cancer treatment. Theseus operations and European Phase II lung cancer trials will be suspended Sept. 15 while awaiting sale. NASI expects to take a related $6 mil. charge. Brachytherapy seed maker NASI acquired IMRT/IGRT firm Nomos for about $56 mil. in May (1"The Gray Sheet" Nov. 3, 2003, p. 23)...
NASI to divest imaging agent R&D
North American Scientific, Inc. will prioritize intensity modulated radiation therapy (IMRT) and image guided radiation therapy (IGRT) oncology therapeutics by redirecting a portion of the $10 mil. annual savings that will result from a planned divestiture of its Theseus radiopharmaceutical R&D operation, the firm says. NASI bought Theseus for about $18.5 mil. in 2000; its primary product candidate is the Hynic-Annexin V nuclear imaging agent for determining early response to chemotherapy cancer treatment. Theseus operations and European Phase II lung cancer trials will be suspended Sept. 15 while awaiting sale. NASI expects to take a related $6 mil. charge. Brachytherapy seed maker NASI acquired IMRT/IGRT firm Nomos for about $56 mil. in May (1"The Gray Sheet" Nov. 3, 2003, p. 23)...
Varian Medical Systems Bolsters Oncology Unit With Zmed Purchase
Varian Medical System's acquisition of SonArray three-dimensional ultrasound technology will enable the firm to enhance its image-guided radiotherapy line for radiation oncology clinics